WO2023031773 - IVT RNA MANUFACTURING PROCESS
National phase entry:
Publication Number
WO/2023/031773
Publication Date
09.03.2023
International Application No.
PCT/IB2022/058089
International Filing Date
29.08.2022
Title **
[English]
IVT RNA MANUFACTURING PROCESS
[French]
PROCÉDÉ DE FABRICATION D'ARN PAR IVT
Applicants **
GLAXOSMITHKLINE BIOLOGICALS SA
Inventors
HALMAN, Justin Ross
VAIDYA, Nilesh
Priority Data
63/238,878
31.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3658 | |
| EPO | Filing, Examination, Granting | 47188 | |
| Japan | Filing, Examination, Granting | 3757 | |
| South Korea | Filing, Examination, Granting | 5200 | |
| USA | Filing, Examination, Granting | 19340 |
Total:
79,143
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Improved methods for manufacturing a RNA by IVT and compositions for use therein are provided.[French]
L'invention concerne des procédés améliorés de fabrication d'un ARN par IVT et des compositions destinées à être utilisées dans ceux-ci.